April 16, 2020
Polish telemedicine innovations company StethoMe has announced they will be rolling out their AI wireless stethoscope following recent collaborations with major telemedicine providers MaQuestionMedicale and HomeDoctor. The company is also in talks with other providers across Europe in the hope of expanding operations.
WHAT IT’S FOR
The EU-certified medical device, which records respiratory...
April 2, 2020
Editor's note: On the same day this story was published, the FDA publicized the first Emergency Use Authorization of a serology test, Cellex Inc.’s qSARS-CoV-2 IgG/IgM Rapid Test. This story has been updated to reflect that development.
On Tuesday morning, Los Angeles-based Bodysphere announced that it had received an Emergency Use Authorization (EUA) for a rapid COVID-19 serology test able to...
February 7, 2020
The first artificial intelligence-enabled cardiac ultrasound software has received De Novo marketing authorization, the FDA announced today. Developed by Caption Health, the Caption Guidance tool guides medical professionals through a heart disease diagnostic test that normally requires an ultrasound expert.
“Echocardiograms are one of the most widely-used diagnostic tools in the diagnosis and...
January 31, 2020
Health tech venture-backed investments continued strong in 2019, hitting a record and cementing health tech as the fastest growing healthcare sector, according to a report by Silicon Valley Bank (SVB).
The Healthcare Investments and Exits Report predicts that health tech investments in Europe and the US will continue to rise in 2020, driven by provider operations and alternative care companies....
Above: Screengrab of the MiRXES website.
January 30, 2020
MicroRNA (MiRNA) is a small RNA molecule that play a central part in the functioning of the human body and are promising markers for identifying the early-stage risk of diseases such as cancer. According to an article published in Clinical Epigenetics in 2018, the differential expression of circulating miRNAs exhibited promising potential for cancer screening without additional injury for...
January 28, 2020
Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers and providers. Her previous positions include the first chief innovation officer at Boston...
The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to clinicians and healthcare providers in the US.
November 18, 2019
UK-based health technology firm Ultromics has received clearance from the US Food and Drug Administration (FDA) for its cardiovascular image analysis system, EchoGo Core.
EchoGo applies artificial intelligence (AI) to automate the analysis and quantification of ultrasound-based heart scans.
The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to...
April 16, 2019
Austin, Texas-based EverlyWell – maker of a digital platform that lets consumers order lab tests online, provide samples and receive results – has raised $50 million in a funding round announced this morning. Goodwater Capital led the round, with additional participation from Highland Capital Partners, Next Coast Ventures, NextGen Venture Partners and other unnamed investors.
WHAT THEY DO...
March 28, 2019
Scanwell Health, the maker of a smartphone-based platform for home urinary tract infection screening, announced last week that it will be playing a role in the Chronic Renal Insufficiency Cohort (CRIC) Study, an ongoing, multicenter investigation of chronic kidney disease and other comorbid chronic conditions sponsored by the National Institutes of Health.
As a result of the partnership, up 1,250...
Above: Screengrab of Burning Rock's website.
February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...